Effect of Probiotic Bacteria on Oral Candida in Frail Elderly
NCT ID: NCT02391532
Last Updated: 2015-08-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
215 participants
INTERVENTIONAL
2013-09-30
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Probiotic Lactobacillus Reuteri and Oral Microbiota
NCT02311218
Efficacy of a Dietary Supplementation With Lactobacillus Reuteri for Digestive Health in an Elderly Population
NCT01837940
Effect of Probiotics on Oral Wound Healing - Pilot Study
NCT03210779
To Demonstrate That Lactobacillus Reuteri ATCC PTA 4659 Survives Passage Through the Gastrointestinal Tract of Humans
NCT01033539
Salivary IgA and Cytokines Response to Dietary Supplementation of Lactobacillus Reuteri
NCT02017886
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
L. reuteri DSM 17938/ATCC PTA
L. reuteri DSM 17938/ATCC PTA lozenges twice daily for 12 weeks
L. reuteri DSM 17938/ATCC PTA
Ingestion of active lozenge twice daily for 12 weeks
Placebo
Placebo lozenges twice daily for 12 weeks
Placebo
Ingestion of placebo lozenge twice daily for 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
L. reuteri DSM 17938/ATCC PTA
Ingestion of active lozenge twice daily for 12 weeks
Placebo
Ingestion of placebo lozenge twice daily for 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ability to cooperate with a dental examination and saliva sampling
Exclusion Criteria
* severe dementia or cognitive impairment
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mette Rose Jørgensen
PhD Student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Svante Twetman, Professor
Role: STUDY_DIRECTOR
University of Copenhagen
References
Explore related publications, articles, or registry entries linked to this study.
Kraft-Bodi E, Jorgensen MR, Keller MK, Kragelund C, Twetman S. Effect of Probiotic Bacteria on Oral Candida in Frail Elderly. J Dent Res. 2015 Sep;94(9 Suppl):181S-6S. doi: 10.1177/0022034515595950. Epub 2015 Jul 22.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010/618
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.